Capital Bank & Trust CO Seagen Inc. Transaction History

Capital Bank & Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $105 Million - $125 Million	-738,917 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $383,627 - $457,524	2,840 Added 0.39%	738,917 $117 Million
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $16.7 Million - $23.1 Million	-121,175 Reduced 14.14%	736,077 $102 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $141 Million - $182 Million	857,252 New	857,252 $150 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.